EMA Consults On Extrapolation Considerations For Antibacterial Agents To Treat Pediatrics
Executive Summary
Draft guidance from the European Medicines Agency explains what data companies should generate when they seek marketing approval for antibacterial agents for treating children, including whether pharmacokinetic data in a limited number of pediatric subjects may be suffice to grant a pediatric indication.